1. P921: UPDATED EFFICACY AND SAFETY RESULTS OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1. (23rd June 2022) Authors: Martínez-López, J.; Moreau, P.; Usmani, S. Z.; Garfall, A.; van de Donk, N. W.; San-Miguel, J. F.; Oriol, A.; Chari, A.; Karlin, L.; Mateos, M.-V.; Popat, R.; Nooka, A. K.; Sidana, S.; Trancucci, D.; Verona, R.; Girgis, S.; Uhlar, C.; Stephenson, T.; Banerjee, A.; Krishnan, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 811 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗